During the past decade, Instituto de Oncologia Angel H. Roffo conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Oncologia Angel H. Roffo" #1 sponsor was "Eisai Inc." with 1 trials, followed by "Janssen-Cilag Ltd." with 1 trials sponsored, "Laboratorio Elea Phoenix S.A." with 1 trials sponsored, "M.D. Anderson Cancer Center" with 1 trials sponsored and "NCIC Clinical Trials Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Oncologia Angel H. Roffo" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Oncologia Angel H. Roffo" are "Advanced Non-small Cell Lung Cancer" (1 trials), "Cervical Adenocarcinoma" (1 trials), "Cervical Squamous Cell Carcinoma, Not Otherwise Specified" (1 trials), "Endometrial Neoplasms" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Instituto de Oncologia Angel H. Roffo" in a lesser frequency.

Most popular intervention types in "Instituto de Oncologia Angel H. Roffo" are "Other" (4 trials), "Drug" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Best support treatment" (1 trials), "Doxorubicin" (1 trials), "Lenvatinib" (1 trials), "Lymph Node Mapping" (1 trials) and "No intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Oncologia Angel H. Roffo" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto de Oncologia Angel H. Roffo". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Instituto de Oncologia Angel H. Roffo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Oncologia Angel H. Roffo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".